Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 804 of 1,261

  1. US 8778354

    Compositions and methods for modulating RSV infection and immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  2. US 8778913

    Antimicrobial compositions for treating microbial infections

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  3. US 8778898

    Oligomer conjugates of heteropentacyclic nucleosides

    Nektar Therapeutics · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  4. US 8778897

    Method of treatment using α-1-adrenergic agonist compounds

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  5. US 8778889

    Antimicrobial decapeptide oral hygiene treatment

    The United States of America as represented by the Secretary of the Army · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  6. US 8778907

    Lactulose for bowel evacuation

    Cumberland Pharmaceuticals Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  7. US 8778934

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  8. US 8778870

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  9. US 8778844

    Structured peptide processing

    BICYCLE THERAPEUTICS LIMITED · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  10. US 8779156

    Analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  11. US 8778940

    Chemical inducers of neurogenesis

    The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  12. US 8778944

    Pyridazinone compounds

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  13. US 8781750

    Cell-type-specific patterns of gene expression

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  14. US 8779001

    Stat3 inhibitors

    The United States of America Dept. of Health and Human Services (DHHS) · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  15. US 8778343

    Antibodies that bind tau oligomers

    The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  16. US 8778398

    Immediate release formulations and dosage forms of gamma-hydroxybutyrate

    Jazz Pharmaceuticals, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  17. US 8778671

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  18. US 8778949

    1-(2-phenoxymethylphenyl)piperazine compounds

    Theravance Biopharma R&D IP, LLC · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  19. US 8778980

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  20. US 8779127

    Processes for preparing substituted pyrimidines

    Vertex Pharmaceuticals Incorporated · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  21. US 8779197

    Aryl amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  22. US 8779129

    Triazinedione derivatives as GABAB receptor modulators

    Addex Pharma, S.A. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  23. US 8779151

    Orally bioavailable caffeic acid related anticancer drugs

    The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  24. US 8781559

    Method of evaluating metabolism of the eye

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.